FAST III
|
The Fractional Flow Reserve or 3D-Quantitative-Coronary-Angiography Based Vessel-FFR Guided Revascularization (FAST III) trial is …
Read more >>
|
|
IVUS CHIP
|
The IntraVascular Ultrasound guidance for Complex High-risk Indicated Procedures (IVUS-CHIP) trial is a randomized controlled, multicenter …
Read more >>
|
|
OPTIMAL
|
The OPtimizaTIon of Left MAin PCI with IntravascuLar Ultrasound (OPTIMAL) trial is a randomized, post-marketing trial in 30 European sites …
Read more >>
|
|
Syntax II
|
SYNTAX II is a European multicenter single-arm study investigating the effectiveness of a new generation stent - incorporating pressure wire assessment (ischemia-driven revascularisation) and ...
Read more >>
|
|
Dessolve III
|
Dessolve III is a prospective, single-blind (patient), randomized, controlled, multicenter study. Approximately 17 sites in Europe will participate. The enrollment required ...
Read more >>
|
|
Talent
|
TALENT is a prospective, randomized, 1:1 balanced, controlled, single-blind, multi-center study comparing clinical outcomes at 12 months between SUPRAFLEX and XIENCE in a “Real world, all comers” patient population ...
Read more >>
|
|
Global leaders
|
The GLOBAL LEADERS trial was an Investigator-Initiated Study (IIS) in which 16,000 “all-comer” patients will be enrolled in approximately 132 sites ...
Read more >>
|
|
Absorb stemi: The Trofi II Study
|
ABSORB STEMI: the TROFI II Study is a European multicenter randomized study to assess the safety and performance of ABSORB bioresorbable scaffold in the treatment of ...
Read more >>
|
|
SYNTAX III Revolution
|
SYNTAX III Revolution: A randomized study to evaluate the feasibility of Heart-Team clinical decision making regarding the optimal (surgical or percutaneous based) revascularization ...
Read more >>
|
|
GALILEO 4D
|
The GALILEO 4D trial is a randomized comparison of a rivaroxaban-based strategy with an antiplatelet-based strategy following successful TAVR for the prevention of leaflet thickening ...
Read more >>
|
|
MASTER DAPT
|
MASTER DAPT is an Investigator-initiated, multi-center, randomized clinical trial in HBR patients after PCI with Ultimaster bioresorbable polymer coated sirolimus-eluting stent implantation.
Read more >>
|
|
POLBOS LM
|
The POLBOS trial is a prospective, multicenter single-arm study in patients with an indication for unprotected left main bifurcation revascularization using the BiOSS LIM C device (Balton, Warsaw, Poland).
Read more >>
|
|